Angarano G - Search Results

1

Mutations in the reverse transcriptase gene of HIV type 1 from subjects after stavudine-didanosine dual therapy.

Monno L, Appice A, Scarabaggio T, Di Stefano M, Pastore G, Angarano G. Monno L, et al. Among authors: angarano g. AIDS Res Hum Retroviruses. 2000 May 20;16(8):821-3. doi: 10.1089/088922200308828. AIDS Res Hum Retroviruses. 2000. PMID: 10826489 Clinical Trial. No abstract available.

2

The role of HIV type 1 phenotype and genotype in long-term responders to zidovudine therapy.

Angarano G, Monno L, Vivirito MC, Appice A, Romanelli C, Giannelli A, La Grasta L, Fracasso C, Fiore JR, Milazzo F. Angarano G, et al. AIDS Res Hum Retroviruses. 1996 Jul 20;12(11):969-75. doi: 10.1089/aid.1996.12.969. AIDS Res Hum Retroviruses. 1996. PMID: 8827212

3

Detection of multiple drug-resistance-associated pol mutations in cervicovaginal secretions from women largely treated with antiretroviral agents.

Di Stefano M, Fiore JR, Monno L, Lepera A, Pastore G, Angarano G. Di Stefano M, et al. Among authors: angarano g. AIDS. 1999 May 28;13(8):992-4. doi: 10.1097/00002030-199905280-00018. AIDS. 1999. PMID: 10371183 No abstract available.

4

Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.

Monno L, Appice A, Cavaliere R, Scarabaggio T, Angarano G. Monno L, et al. Among authors: angarano g. J Infect Dis. 1999 Aug;180(2):568-71. doi: 10.1086/314909. J Infect Dis. 1999. PMID: 10395885 No abstract available.

5

Comparison of once and twice daily dosing of didanosine in combination with stavudine for the treatment of HIV-1 infection. AI 454-146 Team.

Monno L, Cargnel A, Soranzo ML, Chirianni A, Ferraro T, Di Stefano M, Angarano G. Monno L, et al. Among authors: angarano g. Antivir Ther. 1999;4(4):195-202. Antivir Ther. 1999. PMID: 10723498 Clinical Trial.

6

Transmission of zidovudine-resistant HIV-1 through heterosexual contacts.

Angarano G, Monno L, Appice A, Giannelli A, Romanelli C, Fico C, Pastore G. Angarano G, et al. AIDS. 1994 Jul;8(7):1013-4. doi: 10.1097/00002030-199407000-00023. AIDS. 1994. PMID: 7524541 No abstract available.

7

In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalitis.

Di Stefano M, Monno L, Fiore JR, Angarano G. Di Stefano M, et al. Among authors: angarano g. AIDS. 1997 Jan;11(1):133-5. AIDS. 1997. PMID: 9110095 No abstract available.

8

Measurement of viral sequences in cerebrospinal fluid of AIDS patients with cerebral white-matter lesions using polymerase chain reaction.

Monno L, Di Stefano M, Zimatore GB, Andreula CF, Appice A, Perulli LM, Fiore JR, Pastore G, Angarano G. Monno L, et al. Among authors: angarano g. AIDS. 1998 Apr 16;12(6):581-90. doi: 10.1097/00002030-199806000-00006. AIDS. 1998. PMID: 9583597

9

Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype.

Di Stefano M, Monno L, Fiore JR, Buccoliero G, Appice A, Perulli LM, Pastore G, Angarano G. Di Stefano M, et al. Among authors: angarano g. AIDS. 1998 May 7;12(7):737-43. doi: 10.1097/00002030-199807000-00010. AIDS. 1998. PMID: 9619805

10

Phenotypic patterns of HIV-1 clonal populations during highly active antiretroviral therapy (HAART).

Favia A, Di Stefano M, Fiore JR, Pastore G, Angarano G. Favia A, et al. Among authors: angarano g. New Microbiol. 1999 Oct;22(4):301-7. New Microbiol. 1999. PMID: 10555199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

408 results

Search Page

Filters